Loading company…
RedDress Medical develops blood-based wound care systems for treating chronic and difficult-to-heal wounds.
Founded in 2009 by Alon Kushnir and Igal Kushnir, RedDress Medical develops wound care systems that use a patient's blood to support healing. Its products include ActiGraft and ActiGraft+, used for chronic wounds such as diabetic foot ulcers, venous leg ulcers, and pressure ulcers. As of April 2023, its systems were available in 40 countries across five continents. In May 2023, it raised USD 25 million in Series D funding from ATHOS Biopharma GmbH, HCS Capital Partners, and Ragnar Crossover Fund.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in